Fibrosis and expression of extracellular matrix proteins in human interventricular septum in aortic valve stenosis and regurgitation.
David SedmeraAlena KvasilovaAdam EckhardtPetr KacerMartin PenickaMatej KockaDana SchindlerRon KabanRadka KockovaPublished in: Histochemistry and cell biology (2024)
Valvular heart disease leads to ventricular pressure and/or volume overload. Pressure overload leads to fibrosis, which might regress with its resolution, but the limits and details of this reverse remodeling are not known. To gain more insight into the extent and nature of cardiac fibrosis in valve disease, we analyzed needle biopsies taken from the interventricular septum of patients undergoing surgery for valve replacement focusing on the expression and distribution of major extracellular matrix protein involved in this process. Proteomic analysis performed using mass spectrometry revealed an excellent correlation between the expression of collagen type I and III, but there was little correlation with the immunohistochemical staining performed on sister sections, which included antibodies against collagen I, III, fibronectin, sarcomeric actin, and histochemistry for wheat germ agglutinin. Surprisingly, the immunofluorescence intensity did not correlate significantly with the gold standard for fibrosis quantification, which was performed using Picrosirius Red (PSR) staining, unless multiplexed on the same tissue section. There was also little correlation between the immunohistochemical markers and pressure gradient severity. It appears that at least in humans, the immunohistochemical pattern of fibrosis is not clearly correlated with standard Picrosirius Red staining on sister sections or quantitative proteomic data, possibly due to tissue heterogeneity at microscale, comorbidities, or other patient-specific factors. For precise correlation of different types of staining, multiplexing on the same section is the best approach.
Keyphrases
- aortic valve
- extracellular matrix
- aortic stenosis
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- poor prognosis
- aortic valve replacement
- mass spectrometry
- patients undergoing
- left ventricular
- single cell
- flow cytometry
- mitral valve
- liver fibrosis
- high resolution
- heart failure
- minimally invasive
- ultrasound guided
- coronary artery disease
- single molecule
- pulmonary hypertension
- data analysis
- acute coronary syndrome
- liquid chromatography
- percutaneous coronary intervention
- tandem mass spectrometry
- simultaneous determination